13 Results

People

  1. O'Cearbhaill
    O'Cearbhaill
  2. Brentjens
    Brentjens
  3. Riviere
    Riviere
  4. Diamonte
    Diamonte
  5. Halton
    Halton
  6. Adusumilli
    Adusumilli
  7. Sadelain
    Sadelain
  8. Chintala
    Chintala
  9. Zauderer
    Zauderer
  10. Modi
    Modi

Groups

  1. Center for Hematologic Malignancies (13)
  2. Department of Medicine (13)
  3. GDMT, Medicine (13)
  4. GSK Faculty (13)
  5. Gynecologic Medicine Service (13)
  6. Gynecology Disease Management Team (13)
  7. Hematologic Malignancies Research (13)
  8. Hematologic Malignancies, Division of (13)
  9. Solid Tumor Oncology Division (13)
  10. Adult Leukemia (12)
  1. "Hematologic Malignancies Research"
  2. "Hematologic Malignancies, Division of"
  3. "Center for Hematologic Malignancies"
  4. "Roisin O'Cearbhaill"
Formats
  1. Meeting Abstract (8)
  2. Journal Article (5)
Groups
  1. Center for Hematologic Malignancies (13)
  2. Department of Medicine (13)
  3. GDMT, Medicine (13)
  4. GSK Faculty (13)
  5. Gynecologic Medicine Service (13)
  6. Gynecology Disease Management Team (13)

More Groups

People
  1. Roisin O'Cearbhaill (13)
  2. Renier Brentjens (11)
  3. Isabelle Riviere (9)
  4. Claudia Diamonte (7)
  5. Elizabeth Halton (7)
  6. Michel Sadelain (6)

More People

Years
  1. 2021 (4)
  2. 2020 (1)
  3. 2019 (3)
  4. 2018 (4)
  5. 2015 (1)
Publications
  1. Molecular Therapy - Methods & Clinical Development (2)
  2. Annals of Oncology (1)
  3. Biology of Blood and Marrow Transplantation (1)
  4. Blood (1)
  5. Cancer Discovery (1)
  6. Cancer Immunology, Immunotherapy (1)

More Publications

Publishers
  1. American Association for Cancer Research (3)
  2. Nature Publishing Group (3)
  3. Elsevier Inc. (2)
  4. American Society of Clinical Oncology (1)
  5. American Society of Hematology (1)
  6. Biomed Central Ltd (1)

More Publishers

Results (13)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Promoting functional persistence in solid tumor CAR T-cell therapy: Mesothelin-targeted CAR (M28z1XXPD1DNR) with T-cell intrinsic PD1 dominant negative receptor
    Meeting Abstract

    Adusumilli, P. S.; Amador, A. M.; Chintala, N.; Hou, Z.; Offin, M.; Pineda, J.; Senechal, B.; Quach, H. T.; Bellis, R.; Banerjee, S.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • A phase I trial of regional mesothelin-targeted CAR T-cell therapy in patients with malignant pleural disease, in combination with the anti-PD-1 agent pembrolizumab
    Journal Article

    Adusumilli, P. S.; Zauderer, M. G.; Rivière, I.; Solomon, S. B.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Cheema, W.; Chintala, N. K.; Halton, E.; more...
    Cancer Discovery (2021)

    Fulltext@MSK | Save
  • Depletion of high-content CD14(+) cells from apheresis products is critical for successful transduction and expansion of CAR T cells during large-scale cGMP manufacturing
    Journal Article

    Wang, X.; Borquez-Ojeda, O.; Stefanski, J.; Du, F.; Qu, J.; Chaudhari, J.; Thummar, K.; Zhu, M.; Shen, L. B.; Hall, M.; more...
    Molecular Therapy - Methods & Clinical Development (2021)

    Fulltext@MSK | Save
  • Impact of tumor heterogeneity and microenvironment in identifying neoantigens in a patient with ovarian cancer
    Journal Article

    Dao, T.; Klatt, M. G.; Korontsvit, T.; Mun, S. S.; Guzman, S.; Mattar, M.; Zivanovic, O.; Kyi, C. K.; Socci, N. D.; O’Cearbhaill, R. E.; more...
    Cancer Immunology, Immunotherapy (2021)

    Fulltext@MSK | Save
  • A phase I clinical trial of autologous chimeric antigen receptor (CAR) T cells genetically engineered to secrete IL-12 and to target the MUC16ecto antigen in patients (pts) with MUC16ecto+ recurrent high-grade serous ovarian cancer (HGSOC)
    Meeting Abstract

    O'Cearbhaill, R. E.; Park, J. H.; Halton, E. F.; Diamonte, C. R.; Mead, E.; Lakhman, Y.; Kane, P.; Riviere, I. C.; Brentjens, R. J.
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Intestinal microbiome analyses identify biomarkers for patient response to CAR T cell therapy
    Meeting Abstract

    Smith, M.; Littmann, E.; Slingerland, J.; Clurman, A.; Slingerland, A. E.; Taur, Y.; Peled, J. U.; Park, J.; O'Cearbhaill, R.; Mailankody, S.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Regional delivery of mesothelin-targeted CAR T cells for pleural cancers: Safety and preliminary efficacy in combination with anti-PD-1 agent
    Meeting Abstract

    Adusumilli, P. S.; Zauderer, M. G.; Rusch, V. W.; O'Cearbhaill, R.; Zhu, A.; Ngai, D.; McGee, E.; Chintala, N.; Messinger, J.; Cheema, W.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • A phase I clinical trial of malignant pleural disease treated with regionally delivered autologous mesothelin-targeted CAR T cells: Safety and efficacy
    Meeting Abstract

    Adusumilli, P. S.; Zauderer, M. G.; Rusch, V. W.; O'Cearbhaill, R. E.; Zhu, A.; Ngai, D. A.; McGee, E.; Chintala, N. K.; Messinger, J. C.; Vincent, A.; more...
    Cancer Research (2019)

    Fulltext@MSK | Save
  • Intestinal microbiota composition prior to CAR T cell infusion correlates with efficacy and toxicity
    Meeting Abstract

    Smith, M.; Littmann, E. R.; Slingerland, J. B.; Clurman, A.; Slingerland, A. E.; Taur, Y.; Schluter, J.; Park, J. H.; O'Cearbhaill, R.; Mailankody, S.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Screening clinical cell products for replication competent retrovirus: The National Gene Vector Biorepository experience
    Journal Article

    Cornetta, K.; Duffy, L.; Feldman, S. A.; Mackall, C. L.; Davila, M. L.; Curran, K. J.; Junghans, R. P.; Tang, J. Y.; Kochenderfer, J. N.; O'Cearbhaill, R.; more...
    Molecular Therapy - Methods & Clinical Development (2018)

    Fulltext@MSK | Save